Advanced search
Publication Cover
Ophthalmic Genetics Volume 42, 2021 - Issue 3
Submit an article Journal homepage
81
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Norrie disease with a spontaneously shrinking choroid plexus abnormality: a case report

Subhi Talal Younesa School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA;b Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4320-0355
ORCID Icon,
James Mason Shiflettc Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Kristin Weaverc Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Andrew Smithc Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Betty Herringtond Department of Pediatrics, Division of Hematology/Oncology, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Charlotte Taylore Department of Radiology, Division of Neuroradiology, University of Mississippi Medical Center, Jackson, Mississippi, USA
&
Kartik Reddyf Department of Radiology, Division of Neuroradiology, Emory University, Atlanta, Georgia, USA
 show all
Pages 344-348 | Received 21 Oct 2020, Accepted 15 Feb 2021, Published online: 01 Mar 2021

References

  • Nikopoulos K, Venselaar H, Collin RWJ, Riveiro-Alvarez R, Boonstra FN, Hooymans JMM, Mukhopadhyay A, Shears D, van Bers M, de Wijs IJ, et al. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum Mutat. 2010;31:656–66.
  • Paes KT, Wang E, Henze K, Vogel P, Read R, Suwanichkul A, Kirkpatrick LL, Potter D, Newhouse MM, Rice DS, et al. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Investig Ophthalmol Vis Sci. 2011;52:6452.
  • Drenser KA, Fecko A, Dailey W, Trese MT. 2007. A characteristic phenotypic retinal appearance in Norrie disease. Retina. 27(2):243–46. doi:10.1097/01.iae.0000231380.29644.c3.
  • Smith SE, Mullen TE, Graham D, Sims KB, Rehm HL. Norrie disease: extraocular clinical manifestations in 56 patients. Am J Med Genet Part A. 2012;158A:1909–17. doi:10.1002/ajmg.a.35469.
  • Halpin C, Owen G, Gutiérrez-Espeleta GA, Sims K, Rehm HL. Audiologic features of Norrie disease. Ann Otol Rhinol Laryngol. 2005;114:533–38. doi:10.1177/000348940511400707.
  • Lev D, Weigl Y, Hasan M, Gak E, Davidovich M, Vinkler C, Leshinsky-Silver E, Lerman-Sagie T, Watemberg N. A novel missense mutation in the NDP gene in a child with norrie disease and severe neurological involvement including infantile spasms. Am J Med Genet Part A. 2007;143A:921–24.
  • Michaelides M. Norrie disease and peripheral venous insufficiency. Br J Ophthalmol. 2004;88:1475–1475. doi:10.1136/bjo.2004.042556.
  • Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883–95.
  • Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. Wnt/β-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008;183:409–17.
  • Wang Y, Sabbagh MF, Gu X, Rattner A, Williams J, Nathans J. Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures. Elife. 2019. doi:10.7554/eLife.43257.
  • Isashiki Y, Ohba N, Yanagita T, Hokita N, Hotta Y, Hayakawa M, Fujiki K, Tanabe U, et al. Mutations in the Norrie disease gene: A new mutation in a Japanese family. Br J Ophthalmol. 1995;79:703–04.
  • Shuangshoti S, Netsky MG. Neuroepithelial (colloid) cysts of the nervous system: further observations on pathogenesis, location, incidence, and histochemistry. Neurology. 1966;16:887–887. doi:10.1212/WNL.16.9.887.
  • Wolff JEA, Sajedi M, Brant R, Coppes MJ, Egeler RM. Choroid plexus tumours. Br J Cancer. 2002;87:1086–91. doi:10.1038/sj.bjc.6600609.
  • Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol. 2010;28:1995–2001.
  • Wolff JEA, Sajedi M, Coppes MJ, Anderson RA, Maarten Egeler R. Radiation therapy and survival in choroid plexus carcinoma. Lancet. 1999;353:2126. doi:10.1016/S0140-6736(99)01744-4.
  • Wrede B, Liu P, Wolff JEA. Chemotherapy improves the survival of patients with choroid plexus carcinoma: A meta-analysis of individual cases with choroid plexus tumors. J Neurooncol. 2007;85:345–51. doi:10.1007/s11060-007-9428-x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.